| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0031182011000850 |
| P8608 | Fatcat ID | release_lilhnd2bpfh5veen6hvwrxvek4 |
| P698 | PubMed publication ID | 21756423 |
| P2093 | author name string | Renu Tripathi | |
| Swaroop Kumar Pandey | |||
| Amber Rizvi | |||
| P2860 | cites work | Macrolide drug interactions: an update | Q33895235 |
| Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin | Q34049823 | ||
| Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. | Q37160635 | ||
| Reversal of mefloquine and quinine resistance in Plasmodium falciparum with NP30. | Q38947304 | ||
| Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria | Q39188532 | ||
| Mefloquine-resistant falciparum malaria on the Thai-Burmese border | Q39234433 | ||
| Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers | Q39473480 | ||
| In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum | Q39651542 | ||
| Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria | Q40680523 | ||
| Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline | Q41919052 | ||
| In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors | Q41938218 | ||
| Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. | Q41938623 | ||
| Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis | Q42645521 | ||
| Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis | Q43952353 | ||
| The mitochondrial ribosome of the protozoan Acanthamoeba castellanii is the target for macrolide antibiotics | Q44863429 | ||
| CYP isoforms involved in the metabolism of clarithromycin in vitro: comparison between the identification from disappearance rate and that from formation rate of metabolites | Q45201239 | ||
| Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression | Q45286038 | ||
| Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers | Q46492467 | ||
| Mefloquine resistance reversal action of ketoconazole - a cytochrome P450 inhibitor, against mefloquine-resistant malaria | Q46578150 | ||
| Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria | Q47837231 | ||
| Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. | Q51713601 | ||
| Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes | Q73840315 | ||
| P433 | issue | 9 | |
| P921 | main subject | clarithromycin | Q118551 |
| mefloquine | Q736270 | ||
| Plasmodium yoelii | Q12065970 | ||
| P304 | page(s) | 1069-1076 | |
| P577 | publication date | 2011-07-15 | |
| P1433 | published in | Parasitology | Q15753259 |
| P1476 | title | Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice | |
| P478 | volume | 138 |
Search more.